OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Applied Clinical Trials
2004, Merck voluntarily withdraws its COX-2 selective nonsteroidal anti-inflammatory drug for the treatment of pain. This event affected the industry’s image and increased political, public, and industry focus on product safety and risk management.
Related Content:
News